P/B
2,2
Tenaya Therapeutics
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
Tenaya Therapeutics Inc is a preclinical stage biotechnology company focused on discovering, developing, and delivering curative therapies that address the underlying drivers of heart disease. It is advancing product candidates from three product platforms: gene therapy, cellular regeneration and precision medicine.
$152.3M
Market Cap • 9/18/2026
2016
(10 years)
Founded
2021
(5 years ago)
IPO
NASDAQ
Listing Exchange
United States
Country
Valuation
P/S
—
P/EBITDA
—
P/OCF
—
P/FCF
—
P/E
—
BVPS
0,4
EPS
—
Market Cap
Market Cap
152,3M
EV
78,2M
EV/Revenue
0
EV/EBITDA
-0,8
EV/EBIT
-0,7
Payout
Dividend Per Share
0
Dividend Yield
0%
Buyback Yield
-2,1%
Total Yield
-2,1%
Payout
0%
Retained Earnings
-667,7M
Profitability
Gross Margin
—
EBITDA Margin
—
EBIT Margin
—
Net Margin
—
D&A/EBITDA
0%
R&D/Revenue
0%
Capex/Revenue
0%
Capex/D&A
3,7%
Capex/OCF
-0,5%
SBC/OCF
—
% PPE
5,8%
% Goodwill
0%
ROE
—
ROIC
—
Growth
CAGR Op. Income 5Y
16,6%
CAGR Net Income 5Y
16,1%
CAGR EPS 5Y
-58,9%
CAGR OCF 5Y
1,8%
Leverage
N.D./EBITDA
0,8
Debt/Equity
0%
Current Ratio
4,5
Quick Ratio
4,1
Interest Coverage
—
Premium
- Unrestricted access
- Unlimited data history
- Analysis videos
- Quarterly highlights
- Customizable financials table
- Ranking
- Discussions
...and much more!